Hangzhou Tigermed Consulting Co., Ltd. has released an announcement regarding its share repurchase program.

As of June 12, 2026, the company has repurchased a total of 9.0588 million of its own A-shares through a dedicated securities account using centralized competitive bidding.

These repurchased shares represent approximately 1.0521% of the company's current total issued share capital and about 1.2276% of its total A-share capital.

The highest price paid per share was 39.96 yuan, while the lowest price was 38.22 yuan. The total consideration for the buyback amounted to 357 million yuan, excluding transaction fees.

The company confirmed that this share repurchase has been executed in full compliance with its approved buyback plan and all relevant laws and regulations.